Open AccessA Case of Cutaneous Rosai-Dorfman Disease Refractory to Imatinib Therapy
Author(s) -
Carl Gebhardt,
Marco Averbeck,
Uwe Paasch,
Selma Ugurel,
Hjalmar Kurzen,
Patrick Stumpp,
Jan C. Simon,
Regina Treudler
Publication year - 2009
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2008.597
Subject(s) - medicine , imatinib mesylate , histiocyte , imatinib , histiocytosis , rosai–dorfman disease , cd68 , pathology , erdheim–chester disease , disease , dermatology , immunohistochemistry , myeloid leukemia
Rosai-Dorfman disease is a non-Langerhans cell histiocytosis that recently has been treated successfully with imatinib mesylate in a patient with a systemic variant of the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom